Traws Pharma, Inc. Stock-Based Compensation
Traws Pharma, Inc. (TRAW) reported Stock-Based Compensation of $1.45 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- Traws Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $816.00K, a 677.14% increase year-over-year.
- Traws Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $634.00K, a 293.79% increase year-over-year.
- Traws Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $327.00K, a 2.10% decline year-over-year.
- Traws Pharma, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $135.00K, a 60.64% decline year-over-year.
- Traws Pharma, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $728.00K, a 47.63% decline from fiscal 2024.
- Traws Pharma, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $1.39M, a 6.84% increase from fiscal 2023.
- Traws Pharma, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $1.30M, a 11.01% increase from fiscal 2022.
- Traws Pharma, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $1.17M, a 103.47% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $816.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.45M 10-Q · filed 2026-08-14 | $1.78M derived: sum of 3 quarters · filed 2026-08-14 | $1.91M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $634.00K 10-Q · filed 2026-05-15 | $961.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.10M derived: sum of 3 quarters · filed 2026-05-15 | $1.20M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $462.00K derived: sum of 2 quarters · filed 2026-04-15 | $567.00K derived: sum of 3 quarters · filed 2026-08-14 | $728.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $240.00K derived: sum of 2 quarters · filed 2026-08-14 | $401.00K 10-Q · filed 2025-11-13 | $735.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $105.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $266.00K 10-Q · filed 2026-08-14 | $600.00K derived: sum of 3 quarters · filed 2026-08-14 | $943.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $161.00K 10-Q · filed 2026-05-15 | $495.00K derived: sum of 2 quarters · filed 2026-05-15 | $838.00K derived: sum of 3 quarters · filed 2026-05-15 | $1.22M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $334.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $677.00K derived: sum of 2 quarters · filed 2026-04-15 | $1.06M derived: sum of 3 quarters · filed 2026-04-15 | $1.39M 10-K · filed 2026-04-15 |
| 2024-09-30 | $343.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $723.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.06M 10-Q · filed 2025-11-13 | $1.39M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $380.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $713.00K 10-Q · filed 2025-08-14 | $1.04M derived: sum of 3 quarters · filed 2025-08-14 | $1.41M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $333.00K 10-Q · filed 2025-05-15 | $665.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.02M derived: sum of 3 quarters · filed 2025-05-15 | $1.30M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $332.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $692.00K derived: sum of 2 quarters · filed 2025-03-31 | $965.00K derived: sum of 3 quarters · filed 2025-03-31 | $1.30M 10-K · filed 2025-03-31 |
| 2023-09-30 | $360.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $633.00K derived: sum of 2 quarters · filed 2024-11-14 | $969.00K 10-Q · filed 2024-11-14 | $1.30M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-15 | $609.00K 10-Q · filed 2024-08-15 | $939.00K derived: sum of 3 quarters · filed 2024-08-15 | $1.24M derived: sum of 4 quarters · filed 2024-08-15 |
| 2023-03-31 | $336.00K 10-Q · filed 2024-05-15 | $666.00K derived: sum of 2 quarters · filed 2024-05-15 | $971.00K derived: sum of 3 quarters · filed 2024-05-15 | $1.21M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $330.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $635.00K derived: sum of 2 quarters · filed 2024-04-01 | $876.00K derived: sum of 3 quarters · filed 2024-04-01 | $1.17M 10-K · filed 2024-04-01 |
| 2022-09-30 | $305.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $546.00K derived: sum of 2 quarters · filed 2023-11-14 | $842.00K 10-Q · filed 2023-11-14 | $1.10M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $241.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $537.00K 10-Q · filed 2023-08-14 | $798.00K derived: sum of 3 quarters · filed 2023-08-14 | $988.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $296.00K 10-Q · filed 2023-05-15 | $557.00K derived: sum of 2 quarters · filed 2023-05-15 | $747.00K derived: sum of 3 quarters · filed 2023-05-15 | $807.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $451.00K derived: sum of 2 quarters · filed 2023-03-30 | $511.00K derived: sum of 3 quarters · filed 2023-03-30 | $576.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $250.00K derived: sum of 2 quarters · filed 2022-11-14 | $315.00K 10-Q · filed 2022-11-14 | $409.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $125.00K 10-Q · filed 2022-08-15 | $219.00K derived: sum of 3 quarters · filed 2022-08-15 | $309.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $65.00K 10-Q · filed 2022-05-13 | $159.00K derived: sum of 2 quarters · filed 2022-05-13 | $249.00K derived: sum of 3 quarters · filed 2022-05-13 | $341.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $184.00K derived: sum of 2 quarters · filed 2022-03-21 | $276.00K derived: sum of 3 quarters · filed 2022-03-21 | $369.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | $90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $182.00K derived: sum of 2 quarters · filed 2021-11-15 | $275.00K 10-Q · filed 2021-11-15 | $373.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $92.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $185.00K 10-Q · filed 2021-08-16 | $283.00K derived: sum of 3 quarters · filed 2021-08-16 | $428.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $93.00K 10-Q · filed 2021-05-17 | $191.00K derived: sum of 2 quarters · filed 2021-05-17 | $336.00K derived: sum of 3 quarters · filed 2021-05-17 | $491.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $243.00K derived: sum of 2 quarters · filed 2021-03-18 | $398.00K derived: sum of 3 quarters · filed 2021-03-18 | $1.05M 10-K · filed 2021-03-18 |
| 2019-09-30 | $145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $300.00K derived: sum of 2 quarters · filed 2020-11-16 | $950.00K 10-Q · filed 2020-11-16 | $1.26M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $805.00K 10-Q · filed 2020-08-12 | $1.12M derived: sum of 3 quarters · filed 2020-08-12 | $1.41M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $650.00K 10-Q · filed 2020-05-15 | $964.00K derived: sum of 2 quarters · filed 2020-05-15 | $1.26M derived: sum of 3 quarters · filed 2020-05-15 | $1.52M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $609.00K derived: sum of 2 quarters · filed 2020-03-27 | $869.00K derived: sum of 3 quarters · filed 2020-03-27 | $1.15M 10-K · filed 2020-03-27 |
| 2018-09-30 | $295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $555.00K derived: sum of 2 quarters · filed 2019-11-12 | $833.00K 10-Q · filed 2019-11-12 | $1.21M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $538.00K 10-Q · filed 2019-08-14 | $915.00K derived: sum of 3 quarters · filed 2019-08-14 | $1.35M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $278.00K 10-Q · filed 2019-05-15 | $655.00K derived: sum of 2 quarters · filed 2019-05-15 | $1.09M derived: sum of 3 quarters · filed 2019-05-15 | $1.53M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $808.00K derived: sum of 2 quarters · filed 2019-04-01 | $1.25M derived: sum of 3 quarters · filed 2019-04-01 | $1.71M 10-K · filed 2019-04-01 |
| 2017-09-30 | $431.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $875.00K derived: sum of 2 quarters · filed 2018-11-14 | $1.33M 10-Q · filed 2018-11-14 | $1.91M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $444.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $902.00K 10-Q · filed 2018-08-14 | $1.47M derived: sum of 3 quarters · filed 2018-08-14 | $2.05M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | $458.00K 10-Q · filed 2018-05-15 | $1.03M derived: sum of 2 quarters · filed 2018-05-15 | $1.61M derived: sum of 3 quarters · filed 2018-05-15 | $2.22M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | $572.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $1.15M derived: sum of 2 quarters · filed 2018-03-16 | $1.76M derived: sum of 3 quarters · filed 2018-03-16 | $3.93M 10-K · filed 2018-03-16 |
| 2016-09-30 | $576.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.19M derived: sum of 2 quarters · filed 2017-11-09 | $3.36M 10-Q · filed 2017-11-09 | $4.17M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $611.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $2.78M 10-Q · filed 2017-08-14 | $3.59M derived: sum of 3 quarters · filed 2017-08-14 | $4.38M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $2.17M 10-Q · filed 2017-05-15 | $2.98M derived: sum of 2 quarters · filed 2017-05-15 | $3.77M derived: sum of 3 quarters · filed 2017-05-15 | $4.57M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $809.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $1.60M derived: sum of 2 quarters · filed 2017-03-29 | $2.40M derived: sum of 3 quarters · filed 2017-03-29 | $3.79M 10-K · filed 2017-03-29 |
| 2015-09-30 | $791.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $1.59M derived: sum of 2 quarters · filed 2016-11-14 | $2.98M 10-Q · filed 2016-11-14 | $3.82M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $803.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $2.19M 10-Q · filed 2016-08-15 | $3.03M derived: sum of 3 quarters · filed 2016-08-15 | $4.61M derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | $1.38M 10-Q · filed 2016-05-11 | $2.22M derived: sum of 2 quarters · filed 2016-05-11 | $3.81M derived: sum of 3 quarters · filed 2016-05-11 | $5.12M derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | $841.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $2.43M derived: sum of 2 quarters · filed 2016-03-28 | $3.74M derived: sum of 3 quarters · filed 2016-03-28 | $5.07M 10-K · filed 2016-03-28 |
| 2014-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $2.90M derived: sum of 2 quarters · filed 2015-11-12 | $4.23M 10-Q · filed 2015-11-12 | $5.30M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $2.64M 10-Q · filed 2015-08-13 | $3.72M derived: sum of 3 quarters · filed 2015-08-13 | $7.81M derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $1.33M 10-Q · filed 2015-05-15 | $2.40M derived: sum of 2 quarters · filed 2015-05-15 | $6.50M derived: sum of 3 quarters · filed 2015-05-15 | $6.88M derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $5.17M derived: sum of 2 quarters · filed 2015-03-30 | $5.55M derived: sum of 3 quarters · filed 2015-03-30 | $8.02M 10-K · filed 2015-03-30 |
| 2013-09-30 | $4.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $4.47M derived: sum of 2 quarters · filed 2014-11-14 | $6.94M 10-Q · filed 2014-11-14 | $7.55M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-06-30 | $379.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $2.84M 10-Q · filed 2014-08-14 | $3.46M derived: sum of 3 quarters · filed 2015-03-30 | $14.15M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-03-31 | $2.46M 10-Q · filed 2014-05-15 | $3.08M derived: sum of 2 quarters · filed 2015-03-30 | $13.77M derived: sum of 3 quarters · filed 2015-03-30 | |
| 2012-12-31 | $613.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $11.30M derived: sum of 2 quarters · filed 2015-03-30 | $13.84M 10-K · filed 2015-03-30 | |
| 2012-09-30 | $10.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $13.23M 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $2.54M 10-Q · filed 2013-09-06 | |||
| 2011-12-31 | $6.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |